Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T15739 | Target Info | |||
Target Name | Cellular tumor antigen p53 (TP53) | ||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | TP53 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 4 Acid anhydride hydrolases | + | |||
Interacting Target Name | Mitotic growth and transcription activator (BAF190A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription activator BRG1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4; SNF2L4; SNF2-beta; SNF2B; Protein BRG-1; Protein brahma homolog 1; BRG1-associated factor 190A; BRG1; ATP-dependent helicase SMARCA4 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Co-fractionation | [1] | |||
3 | Reconstituted Complex | [1] | |||
Interacting Target Name | Endoplasmic reticulum chaperone BiP (HSPA5) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Immunoglobulin heavy chain-binding protein; Immunoglobulin heavy chainbinding protein; HSP70 family protein 5; Heat shock protein family A member 5; Heat shock protein 70 family protein 5; Heat shock 70 kDa protein 5; GRP-78; GRP78; Endoplasmic reticulum lumenal Ca(2+)binding protein grp78; BiP; Binding-immunoglobulin protein; 78 kDa glucose-regulated protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [3] | |||
Interacting Protein Name | General transcription and DNA repair factor IIH helicase subunit XPD (ERCC2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | COFS2; EM9; TFIIH; TTD; XPD | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Far Western | [4] | |||
2 | Reconstituted Complex | [5] | |||
Interacting Protein Name | General transcription and DNA repair factor IIH helicase subunit XPB (ERCC3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BTF2; GTF2H; RAD25; TFIIH; XPB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Reconstituted Complex | [5] | |||
Acyltransferases | [+] 15 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [6] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Biochemical Activity | [7] | |||
4 | Co-crystal Structure | [8] | |||
5 | Co-fractionation | [9] | |||
6 | Co-localization | [10] | |||
7 | Protein-peptide | [11] | |||
8 | Reconstituted Complex | [12] | |||
Interacting Target Name | Histone acetyltransferase KAT2B (KAT2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Spermidine acetyltransferase KAT2B; PCAF; P300/CBP-associated factor; P/CAF; Lysine acetyltransferase 2B; Histone acetyltransferase PCAF; Histone acetylase PCAF | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Biochemical Activity | [14] | |||
3 | Reconstituted Complex | [15] | |||
4 | Yeast two hybrid | [16] | |||
Interacting Target Name | Renal carcinoma antigen NY-REN-54 (UBE3A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-protein ligase E3A; Oncogenic protein-associated protein E6-AP; Human papillomavirus E6-associated protein; HPVE6A; HECT-type ubiquitin transferase E3A; EPVE6AP; E6AP ubiquitin-protein ligase; E6AP | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Biochemical Activity | [18] | |||
3 | Co-crystal Structure | [17] | |||
4 | Reconstituted Complex | [19] | |||
Interacting Target Name | E3 ubiquitin-protein ligase COP1 (RFWD2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF200; RING-type E3 ubiquitin transferase RFWD2; RING finger protein 200; RING finger and WD repeat domain protein 2; hCOP1; E3 ubiquitinprotein ligase RFWD2; COP1; Constitutive photomorphogenesis protein 1 homolog | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Biochemical Activity | [20] | |||
3 | Reconstituted Complex | [20] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase CHIP (STUB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CHIP; HSPABP2; NY.CO.7; SCAR16; SDCCAG7; UBOX1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [21] | |||
3 | Reconstituted Complex | [22] | |||
Interacting Protein Name | E3 SUMO-protein ligase PIAS1 (PIAS1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DDXBP1; GBP; GU/RH.II; ZMIZ3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Co-localization | [23] | |||
2 | Reconstituted Complex | [24] | |||
3 | Yeast two hybrid | [25] | |||
Interacting Protein Name | E3 SUMO-protein ligase PIAS2 (PIAS2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ARIP3; DIP; MIZ; MIZ1; PIASX; PIASX.ALPHA; PIASX.BETA; SIZ2; ZMIZ4 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Co-localization | [23] | |||
2 | Reconstituted Complex | [26] | |||
3 | Yeast two hybrid | [27] | |||
Interacting Protein Name | SUMO-conjugating enzyme UBC9 (UBE2I) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C358B7.1; P18; UBC9 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Reconstituted Complex | [29] | |||
3 | Yeast two hybrid | [25] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase UBR5 (UBR5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DD5; EDD; EDD1; HYD | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [30] | |||
3 | Reconstituted Complex | [30] | |||
Interacting Protein Name | Breast cancer type 1 susceptibility protein (BRCA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BRCAI; BRCC1; BROVCA1; FANCS; IRIS; PNCA4; PPP1R53; PSCP; RNF53 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Reconstituted Complex | [32] | |||
Interacting Protein Name | Transcription factor E4F1 (E4F1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E4F | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [33] | |||
2 | Yeast two hybrid | [34] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase HUWE1 (HUWE1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ARF.BP1; HECTH9; HSPC272; Ib772; LASU1; MULE; URE.B1; UREB1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [35] | |||
2 | Reconstituted Complex | [35] | |||
Interacting Protein Name | Histone acetyltransferase KAT2A (KAT2A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GCN5; GCN5L2; PCAF.b; hGCN5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Fluorescence Resonance Energy Transfer | [37] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase RNF38 (RNF38) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [38] | |||
2 | Reconstituted Complex | [39] | |||
Interacting Target Name | Zinc finger protein A20 (TNFAIP3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor necrosis factor, alpha-induced protein3; Tumor necrosis factor alpha-induced protein 3; TNF alpha-induced protein 3; Putative DNA-binding protein A20; Putative DNA binding protein A20; OTUD7C; OTU domain-containing protein 7C; A20 | ||||
Evidence Score (E-score) | 1 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Target Name | Sequestosome-1 p62 (SQSTM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-binding protein p62; Sequestosome-1; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62kDa; Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa; OSIL; ORCA; EBIAP; EBI3-associated protein of 60 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Reconstituted Complex | [41] | |||
Alpha-type channels | [+] 2 Alpha-type channels | + | |||
Interacting Target Name | Apoptosis regulator BAK (BAK) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDN1; Bcl-2-like protein 7; Bcl2like protein 7; Bcl2-L-7; Bcl2L7; Bcl-2 homologous antagonist/killer; Bcl2 homologous antagonist/killer | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [42] | |||
2 | Affinity Capture-Western | [42] | |||
3 | Co-fractionation | [43] | |||
4 | Reconstituted Complex | [42] | |||
Interacting Target Name | Apoptosis regulator Bcl-xL (BCL-xL) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Bcl-XL; BCLX; Bcl-2-like protein 1; Bcl2like protein 1; Bcl2-L-1; Bcl2L1; BCL2L; Apoptosis regulator Bcl-X | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [44] | |||
2 | Reconstituted Complex | [45] | |||
3 | Yeast two hybrid | [46] | |||
Auxiliary transporters | [+] 2 Auxiliary transporters | + | |||
Interacting Target Name | Apoptosis regulator Bcl-W (BCL-W) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAA0271; BCLW; Bcl-2-like protein 2; Bcl2-L-2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [44] | |||
2 | Protein-peptide | [47] | |||
3 | Reconstituted Complex | [44] | |||
Interacting Target Name | S100 calcium-binding protein A4 (S100A4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein S100-A4; Protein Mts1; Placental calcium-binding protein; MTS1; Metastasin; CAPL; Calvasculin | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [48] | |||
2 | Reconstituted Complex | [49] | |||
Carbon-nitrogen hydrolases | [+] 4 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Biochemical Activity | [51] | |||
3 | Co-localization | [23] | |||
4 | Reconstituted Complex | [52] | |||
Interacting Target Name | NAD-dependent deacetylase sirtuin-1 (SIRT1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIR2-like protein 1; SIR2L1; Regulatory protein SIR2 homolog 1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; hSIR2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [53] | |||
2 | Biochemical Activity | [54] | |||
3 | Reconstituted Complex | [54] | |||
Interacting Target Name | Peptidyl arginine deiminase type IV (PADI4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein-arginine deiminase type-4; Protein-arginine deiminase type IV; Peptidylarginine deiminase IV; PDI5; PADI5; PAD4; HL-60 PAD | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [55] | |||
2 | Co-localization | [55] | |||
3 | Reconstituted Complex | [55] | |||
Interacting Target Name | Histone deacetylase 2 (HDAC2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [56] | |||
2 | Reconstituted Complex | [57] | |||
Cell cycle related proteins | [+] 1 Cell cycle related proteins | + | |||
Interacting Target Name | Multiple tumor suppressor 1 (CDKN2A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour suppressor gene p16; P16-INK4a; p16INK4A; P16-INK4; P16 gene; MTS-1; Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [33] | |||
2 | Fluorescence Resonance Energy Transfer | [37] | |||
Cullins | [+] 2 Cullins | + | |||
Interacting Target Name | Cullin-7 (CUL-7) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAA0076 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [58] | |||
2 | Affinity Capture-Western | [59] | |||
3 | Reconstituted Complex | [60] | |||
4 | Yeast two hybrid | [59] | |||
Interacting Protein Name | Cullin-9 (CUL9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | H7AP1; PARC | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [61] | |||
2 | Affinity Capture-Western | [61] | |||
3 | Co-purification | [61] | |||
4 | Reconstituted Complex | [61] | |||
Ester hydrolases | [+] 2 Ester hydrolases | + | |||
Interacting Target Name | Phosphatase and tensin homolog (PTEN) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TEP1; Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN; Phosphatidylinositol 3,4,5trisphosphate 3phosphatase and dualspecificity protein phosphatase PTEN; Mutated in multiple advanced cancers 1; MMAC1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [62] | |||
2 | Reconstituted Complex | [63] | |||
Interacting Protein Name | PP2A subunit A isoform PR65-alpha (PPP2R1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PP2A.Aalpha; PP2AAALPHA; PR65A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [64] | |||
2 | Co-localization | [23] | |||
FAM proteins | [+] 1 FAM proteins | + | |||
Interacting Protein Name | BRISC complex subunit Abraxas 2 (ABRAXAS2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ABRO1; KIAA0157 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [58] | |||
2 | Affinity Capture-Western | [65] | |||
3 | Reconstituted Complex | [65] | |||
Heat shock proteins | [+] 6 Heat shock proteins | + | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [66] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-Western | [67] | |||
4 | Biochemical Activity | [68] | |||
5 | Reconstituted Complex | [69] | |||
Interacting Target Name | Lipopolysaccharide-associated protein 1 (HSPA8) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LPS-associated protein 1; LAP-1; HSPA10; HSP73; HSC70; Heat shock protein 73; Heat shock cognate 71 kDa protein; Heat shock 70 kDa protein 8 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [70] | |||
2 | Affinity Capture-MS | [21] | |||
3 | Affinity Capture-Western | [71] | |||
4 | Reconstituted Complex | [72] | |||
Interacting Target Name | Mortalin (HSPA9) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-70 protein, mitochondrial; Peptide-binding protein 74; PBP74; mt-HSP70; MOT; HSPA9B; Heat shock 70 kDa protein 9; GRP-75; GRP75; 75 kDa glucose-regulated protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [3] | |||
3 | Yeast two hybrid | [73] | |||
Interacting Protein Name | Heat shock 70 kDa protein 1A (HSPA1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HEL.S.103; HSP70.1; HSP70.1A; HSP70I; HSP72; HSPA1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [71] | |||
Interacting Protein Name | Heat shock 70 kDa protein 1B (HSPA1B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HSP70.1B; HSP70.2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Co-localization | [23] | |||
Interacting Protein Name | Heat shock protein beta-1 (HSPB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-responsive protein 27; SRP27; HspB1; HSP28; HSP 27; Heat shock protein beta-1; Heat shock 27 kDa protein; Estrogen-regulated 24 kDa protein; 28 kDa heat shock protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-localization | [23] | |||
2 | Yeast two hybrid | [74] | |||
Isomerases | [+] 2 Isomerases | + | |||
Interacting Target Name | Rotamase Pin1 (PIN1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Prolyl isomerase Pin1; PPIase Pin1; Peptidyl-prolyl cis-trans isomerase Pin1; Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; Peptidyl prolyl cis/trans isomerase Pin1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [75] | |||
2 | Reconstituted Complex | [76] | |||
3 | Yeast two hybrid | [46] | |||
Interacting Target Name | DNA topoisomerase I (TOP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DNA topoisomerase I | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [77] | |||
2 | Yeast two hybrid | [78] | |||
Kinases | [+] 20 Kinases | + | |||
Interacting Target Name | Aurora kinase A (AURKA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | STK6; STK15; Serine/threonine-protein kinase aurora-A; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase 15; Serine/threonine kinase 15; IAK1; hARK1; BTAK; Breast tumor-amplified kinase; AYK1; Aurora-related kinase 1; Aurora-A; Aurora/IPL1-related kinase 1; Aurora 2; AURA; ARK-1; ARK1; AIRK1; AIK | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [58] | |||
2 | Affinity Capture-Western | [79] | |||
3 | Biochemical Activity | [80] | |||
4 | Reconstituted Complex | [79] | |||
5 | Yeast two hybrid | [79] | |||
Interacting Target Name | Casein kinase II alpha (CSNK2A1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein kinase CK2; CK2A1; CK II alpha; CK II; Casein kinase II subunit alpha | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [81] | |||
3 | Biochemical Activity | [82] | |||
4 | Co-localization | [23] | |||
5 | Reconstituted Complex | [69] | |||
Interacting Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [83] | |||
3 | Co-localization | [23] | |||
4 | Protein-Fragment Complementation Assay | [84] | |||
Interacting Target Name | Stress-activated protein kinase JNK1 (JNK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1c; SAPK1c; SAPK1; PRKM8; Mitogen-activated protein kinase 8; MAPK 8; MAP kinase 8; JNK-46; C-Jun N-terminal kinase 1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [85] | |||
2 | Biochemical Activity | [86] | |||
3 | Reconstituted Complex | [87] | |||
4 | Yeast two hybrid | [88] | |||
Interacting Target Name | ATM serine/threonine kinase (ATM) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine-protein kinase ATM; Ataxia telangiectasia mutated; A-T mutated | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Biochemical Activity | [89] | |||
2 | Co-localization | [90] | |||
3 | Protein-peptide | [91] | |||
4 | Reconstituted Complex | [92] | |||
Interacting Target Name | Serine/threonine-protein kinase ATR (FRP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FRAP-related protein 1; Ataxia telangiectasia and Rad3-related protein | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [93] | |||
2 | Biochemical Activity | [94] | |||
3 | Protein-peptide | [91] | |||
4 | Reconstituted Complex | [95] | |||
Interacting Target Name | Homeodomain interacting protein kinase 2 (HIPK2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Homeodomain-interacting protein kinase 2; hHIPk2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [96] | |||
2 | Biochemical Activity | [96] | |||
3 | Reconstituted Complex | [96] | |||
4 | Yeast two hybrid | [97] | |||
Interacting Target Name | Checkpoint kinase-1 (CHK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase Chk1; CHK1 checkpoint homolog; Chk1; Cell cycle checkpoint kinase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [98] | |||
2 | Biochemical Activity | [99] | |||
3 | Co-localization | [100] | |||
Interacting Target Name | Stress-activated protein kinase 2a (p38 alpha) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SAPK2A; P38 Mitogen-activatedprotein kinase alpha; P38 mitogen activatedprotein kinase; MXI2; Mitogen-activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; MAX-interacting protein 2; MAPK 14; MAP kinase p38alpha; MAP kinase p38 alpha; MAP kinase MXI2; MAP kinase 14; Cytokine suppressive anti-inflammatory drug-binding protein; Cytokine suppressive anti-inflammatory drug binding protein; CSPB1; CSBP2; CSBP1; CSBP; CSAID-binding protein; CSAID binding protein; CRK1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [101] | |||
2 | Biochemical Activity | [102] | |||
3 | Protein-Fragment Complementation Assay | [84] | |||
Interacting Target Name | Focal adhesion kinase 1 (FAK) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; pp125FAK; p125FAK; FRNK; Focal adhesion kinase-related nonkinase; FAK1; FADK 1; FADK | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [103] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [103] | |||
Interacting Target Name | DNA-dependent protein kinase catalytic (PRKDC) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P460; HYRC1; HYRC; DNPK1; DNA-PKcs; DNA-PK catalytic subunit; DNA-PK; DNA-dependent protein kinase catalytic subunit; DNA-dependent protein kinase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [104] | |||
2 | Biochemical Activity | [99] | |||
3 | Protein-peptide | [91] | |||
Interacting Target Name | Tyrosine-protein kinase EIF2AK2 (p68) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Proteinkinase RNA-activated; Protein kinase RNA-activated; Protein kinase R; PRKR; PKR; p68 kinase; P1/eIF-2A protein kinase; Interferon-inducible RNA-dependent protein kinase; Interferon-induced, double-stranded RNA-activated protein kinase; Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase 2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [105] | |||
2 | Biochemical Activity | [105] | |||
3 | Reconstituted Complex | [105] | |||
Interacting Target Name | Casein kinase I delta (CSNK1D) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tau-protein kinase CSNK1D; HCKID; CKI-delta; CKId; Casein kinase I isoform delta | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [106] | |||
2 | Biochemical Activity | [107] | |||
3 | Co-localization | [23] | |||
Interacting Target Name | Glycogen synthase kinase-3 beta (GSK-3B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Serine/threonine-protein kinase GSK3B; GSK-3 beta | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [108] | |||
2 | Yeast two hybrid | [46] | |||
Interacting Target Name | Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [109] | |||
2 | Biochemical Activity | [110] | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [110] | |||
2 | Co-localization | [23] | |||
Interacting Target Name | Cyclin-dependent kinase 7 (CDK7) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TFIIH basal transcription factor complex kinase subunit; Serine/threonine-protein kinase 1; P39 Mo15; MO15; Cell division protein kinase 7; CDKN7; CDK-activating kinase 1; CDK-activating kinase; CAK1; CAK; 39 kDa protein kinase | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [111] | |||
2 | Biochemical Activity | [112] | |||
Interacting Target Name | Serine/threonine-protein kinase Chk2 (RAD53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Hucds1; hCds1; CHK2 checkpoint homolog; CHK2; Checkpoint kinase 2; Cds1 homolog; Cds1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [113] | |||
2 | Biochemical Activity | [114] | |||
Interacting Target Name | MAPK/ERK kinase kinase 1 (MAP3K1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Mitogen-activated protein kinase kinase kinase 1; Mitogenactivated protein kinase kinase kinase 1; MEKK1; MEKK 1; MEKK; MEK kinase 1; MAPKKK1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [115] | |||
2 | Reconstituted Complex | [116] | |||
Interacting Protein Name | Serine/threonine-protein kinase STK11 (STK11) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | LKB1; PJS; hLKB1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [117] | |||
2 | Fluorescence Resonance Energy Transfer | [37] | |||
Nuclear hormone receptors | [+] 3 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [118] | |||
2 | Reconstituted Complex | [119] | |||
Interacting Target Name | Hepatocyte nuclear factor 4-alpha (HNF4A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HNF-4; Transcription factor 14; TCF-14; TCF14; Nuclear receptor subfamily 2 group A member 1; NR2A1; HNF-4-alpha; HNF4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [58] | |||
2 | Reconstituted Complex | [120] | |||
Interacting Target Name | Orphan nuclear receptor SHP (NR0B2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Small heterodimer partner; SHP; Short heterodimer partner; Nuclear receptor subfamily 0 group B member 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [121] | |||
2 | Reconstituted Complex | [122] | |||
One-carbon transferases | [+] 3 One-carbon transferases | + | |||
Interacting Target Name | Histone-lysine N-methyltransferase SETD7 (SETD7) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SET9; SET7/9; SET7; SET domain-containing protein 7; Lysine N-methyltransferase 7; KMT7; KIAA1717; Histone H3-K4 methyltransferase SETD7; H3-K4-HMTase SETD7 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Biochemical Activity | [123] | |||
2 | Co-crystal Structure | [124] | |||
3 | Yeast two hybrid | [125] | |||
Interacting Target Name | SET and MYND domain-containing protein 2 (SMYD2) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N-lysine methyltransferase SMYD2; Nlysine methyltransferase SMYD2; Lysine N-methyltransferase 3C; Lysine Nmethyltransferase 3C; KMT3C; HSKM-B; HSKMB; Histone methyltransferase SMYD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [126] | |||
2 | Biochemical Activity | [123] | |||
Interacting Target Name | Mixed-lineage leukemia protein (MLL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Zinc finger protein HRX; Trithorax-like protein; Trithoraxlike protein; p320; p180; Myeloid/lymphoid or mixed-lineage leukemia protein 1; Myeloid/lymphoid or mixed-lineage leukemia; MLL1; MLL cleavage product C180; Lysine N-methyltransferase 2A; Lysine Nmethyltransferase 2A; HTRX; HRX; Histonelysine Nmethyltransferase MLL; Histone-lysine N-methyltransferase 2A; CXXC-type zinc finger protein 7; CXXCtype zinc finger protein 7; CXXC7; ALL-1; ALL1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Reconstituted Complex | [127] | |||
Oxidoreductases | [+] 2 Oxidoreductases | + | |||
Interacting Target Name | Prostaglandin G/H synthase 2 (COX-2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Prostaglandin-endoperoxide synthase 2; Prostaglandin H2 synthase 2; PHS II; PGHS-2; PGH synthase 2; Cytochrome c oxidase polypeptide II; Cyclooxygenase-2; COX2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [128] | |||
2 | Co-purification | [129] | |||
3 | Reconstituted Complex | [130] | |||
Interacting Target Name | Lysine-specific histone demethylase 1 (LSD) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Lysine-specific histone demethylase 1A; Lysinespecific histone demethylase 1A; LSD1; KIAA0601; KDM1; Flavin-containing amine oxidase domain-containing protein 2; Flavincontaining amine oxidase domaincontaining protein 2; BRAF35-HDAC complex protein BHC110; BRAF35HDAC complex protein BHC110; AOF2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [131] | |||
2 | Biochemical Activity | [132] | |||
3 | Reconstituted Complex | [131] | |||
Peptidases | [+] 4 Peptidases | + | |||
Interacting Target Name | Herpesvirus ubiquitin-specific protease (HAUSP) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ubiquitin-specific-processing protease 7; Ubiquitin thioesterase 7; Ubiquitin carboxyl-terminal hydrolase 7; Herpesvirus-associated ubiquitin-specific protease; Deubiquitinating enzyme 7 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [133] | |||
2 | Affinity Capture-Western | [133] | |||
3 | Biochemical Activity | [133] | |||
4 | Co-crystal Structure | [134] | |||
5 | Protein-peptide | [135] | |||
6 | Reconstituted Complex | [136] | |||
Interacting Target Name | JUN activation domain binding protein (COPS5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Signalosome subunit 5; SGN5; Jun activation domain-binding protein 1; JAB1; CSN5; COP9 signalosome complex subunit 5 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [137] | |||
2 | Far Western | [138] | |||
3 | Reconstituted Complex | [137] | |||
Interacting Protein Name | OTU domain-containing protein 5 (OTUD5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DUBA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [139] | |||
2 | Reconstituted Complex | [139] | |||
3 | Yeast two hybrid | [139] | |||
Interacting Protein Name | Ubiquitin carboxyl-terminal hydrolase 10 (USP10) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | UBPO | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [140] | |||
2 | Reconstituted Complex | [140] | |||
Proteins 14-3-3 | [+] 1 Proteins 14-3-3 | + | |||
Interacting Protein Name | 14-3-3 protein sigma (SFN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | YWHAS | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [98] | |||
2 | Reconstituted Complex | [141] | |||
Ribosomal proteins | [+] 4 Ribosomal proteins | + | |||
Interacting Protein Name | Large ribosomal subunit protein uL5 (RPL11) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA7; GIG34; L11 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [142] | |||
Interacting Protein Name | Large ribosomal subunit protein uL14 (RPL23) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | L23; rpL17 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [142] | |||
Interacting Protein Name | Large ribosomal subunit protein uL18 (RPL5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA6; L5; PPP1R135 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [142] | |||
Interacting Protein Name | Small ribosomal subunit protein Es10 (RPS10) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DBA9; S10 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Yeast two hybrid | [143] | |||
Transcription regulators | [+] 23 Transcription regulators | + | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [144] | |||
2 | Affinity Capture-Western | [145] | |||
3 | Biochemical Activity | [146] | |||
4 | Co-crystal Structure | [147] | |||
5 | Co-localization | [148] | |||
6 | Fluorescence Resonance Energy Transfer | [149] | |||
7 | Protein-peptide | [150] | |||
8 | Reconstituted Complex | [151] | |||
Interacting Target Name | AP-2 transcription factor (TFAP2A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor AP-2-alpha; TFAP2; AP2TF; AP2-alpha; AP-2; Activator protein 2; Activating enhancer-binding protein 2-alpha | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [152] | |||
2 | Co-localization | [152] | |||
3 | Reconstituted Complex | [153] | |||
4 | Yeast two hybrid | [152] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [154] | |||
2 | Co-localization | [155] | |||
3 | Reconstituted Complex | [156] | |||
Interacting Target Name | Cyclic AMP-responsive element-binding protein (CREB1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-responsive element-binding protein 1; Cyclic AMP responseelement-binding protein; CREB-1; CREB; cAMP-responsive element-binding protein 1; CAMP-response element binding protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [157] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [158] | |||
Interacting Target Name | Metastasis associated gene-1 (MTA1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Metastasis-associated protein MTA1; Metastasisassociated protein MTA1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [159] | |||
2 | Co-localization | [160] | |||
3 | Reconstituted Complex | [161] | |||
Interacting Target Name | Cyclic-AMP-dependent transcription factor ATF-3 (ATF3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclic AMP-dependent transcription factor ATF-3; cAMP-dependent transcription factor ATF-3; Activating transcription factor 3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [162] | |||
2 | Reconstituted Complex | [162] | |||
3 | Yeast two hybrid | [74] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | Preclinical Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; MMad3; MADH3; Mad3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [163] | |||
2 | Co-localization | [164] | |||
3 | Reconstituted Complex | [163] | |||
Interacting Protein Name | Mothers against decapentaplegic homolog 2 (SMAD2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JV18; JV18.1; MADH2; MADR2; hMAD.2; hSMAD2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [163] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [163] | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [165] | |||
2 | Reconstituted Complex | [166] | |||
Interacting Target Name | Early growth response protein 1 (EGR-1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ZNF225; Zinc finger protein Krox-24; Zinc finger protein Krox24; Zinc finger protein 225; Transcription factor Zif268; Transcription factor ETR103; NGFI-A; NGFIA; Nerve growth factor-induced protein A; Nerve growth factorinduced protein A; KROX24; AT225 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [167] | |||
2 | Reconstituted Complex | [167] | |||
Interacting Target Name | High mobility group protein B1 (HMGB1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HMG-1; HMG1; High mobility group protein 1; High mobility group box chromosomal protein 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [168] | |||
2 | Reconstituted Complex | [168] | |||
Interacting Target Name | Twist-related protein 1 (TWIST1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TWIST; H-twist; Class A basic helix-loop-helix protein 38; bHLHa38 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [169] | |||
2 | Reconstituted Complex | [170] | |||
Interacting Protein Name | Cyclin-D-binding Myb-like transcription factor 1 (DMTF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DMP1; DMTF; MRUL; hDMP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [171] | |||
2 | Reconstituted Complex | [172] | |||
Interacting Protein Name | Nuclear receptor corepressor 1 (NCOR1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | N.CoR; N.CoR1; PPP1R109; TRAC1; hN.CoR | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [173] | |||
2 | Co-localization | [164] | |||
Interacting Protein Name | Zinc finger protein 278 (PATZ1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MAZR; PATZ; RIAZ; ZBTB19; ZNF278; ZSG; dJ400N23 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [174] | |||
2 | Reconstituted Complex | [174] | |||
Interacting Protein Name | Period circadian protein homolog 2 (PER2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FASPS; FASPS1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [175] | |||
2 | Reconstituted Complex | [176] | |||
Interacting Protein Name | SWI/SNF complex subunit SMARCC1 (SMARCC1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BAF155; CRACC1; Rsc8; SRG3; SWI3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [177] | |||
2 | Co-fractionation | [1] | |||
Interacting Protein Name | Transcriptional adapter 3 (TADA3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ADA3; NGG1; STAF54; TADA3L; hADA3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [36] | |||
Interacting Protein Name | TATA-box-binding protein (TBP) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | GTF2D; GTF2D1; HDL4; SCA17; TFIID | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Reconstituted Complex | [178] | |||
Interacting Protein Name | Transcription factor p65 (RELA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | NFKB3; p65 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [145] | |||
2 | Fluorescence Resonance Energy Transfer | [37] | |||
Interacting Protein Name | Transcriptional repressor protein YY1 (YY1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DELTA; INO80S; NF.E1; UCRBP; YIN.YANG.1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [179] | |||
2 | Reconstituted Complex | [180] | |||
Interacting Protein Name | Nuclease-sensitive element-binding protein 1 (YBX1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BP.8; CSDA2; CSDB; DBPB; MDR.NF1; NSEP.1; NSEP1; YB.1; YB1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [181] | |||
Interacting Protein Name | Zinc finger protein 420 (ZNF420) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APAK | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [182] | |||
2 | Reconstituted Complex | [182] | |||
Ubiquitin related proteins | [+] 3 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [6] | |||
2 | Affinity Capture-MS | [58] | |||
3 | Affinity Capture-Western | [183] | |||
4 | Biochemical Activity | [184] | |||
5 | Co-crystal Structure | [185] | |||
6 | Co-fractionation | [9] | |||
7 | Protein-Fragment Complementation Assay | [186] | |||
8 | Reconstituted Complex | [187] | |||
Interacting Target Name | Synovial apoptosis inhibitor 1 (SYVN1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase synoviolin; KIAA1810; HRD1; E3 ubiquitin-protein ligase synoviolin; E3 ubiquitinprotein ligase synoviolin | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [188] | |||
2 | Biochemical Activity | [189] | |||
3 | Co-localization | [189] | |||
4 | Reconstituted Complex | [189] | |||
Interacting Protein Name | Ubiquitin conjugation factor E4 B (UBE4B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | E4; HDNB1; UBOX3; UFD2; UFD2A | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [190] | |||
2 | Co-fractionation | [191] | |||
3 | Reconstituted Complex | [191] | |||
Other proteins | [+] 33 Other proteins | + | |||
Interacting Target Name | Tumor suppressor p53-binding protein 1 (TP53BP1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TP53-binding protein 1; p53BP1; p53-binding protein 1; 53BP1 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [144] | |||
2 | Affinity Capture-Western | [192] | |||
3 | Co-crystal Structure | [193] | |||
4 | Co-localization | [100] | |||
5 | Protein-peptide | [194] | |||
6 | Reconstituted Complex | [195] | |||
7 | Yeast two hybrid | [196] | |||
Interacting Target Name | p53-binding protein Mdm4 (MDM4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein Mdmx; p53-binding protein Mdm4; Mdm2-like p53-binding protein; Double minute 4 protein | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [197] | |||
2 | Affinity Capture-Western | [198] | |||
3 | Fluorescence Resonance Energy Transfer | [37] | |||
4 | Protein-Fragment Complementation Assay | [199] | |||
5 | Protein-peptide | [200] | |||
6 | Reconstituted Complex | [198] | |||
Interacting Target Name | DNA repair protein RAD51 homolog 1 (RAD51) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RECA; RAD51A; RAD51 homolog A; HsRAD51; HRAD51 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [201] | |||
2 | Affinity Capture-Western | [202] | |||
3 | Co-purification | [201] | |||
4 | Reconstituted Complex | [203] | |||
Interacting Protein Name | Small integral membrane protein 40 (SMIM40) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BING2; DAP6; EAP1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [204] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [205] | |||
4 | Yeast two hybrid | [204] | |||
Interacting Target Name | Poly [ADP-ribose] polymerase 1 (PARP1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein poly-ADP-ribosyltransferase PARP1; PPOL; Poly[ADP-ribose] synthetase-1; Poly[ADP-ribose] synthase 1; Poly(ADP-ribose)polymerase-1; PARP-1; NAD(+)Poly [ADP-ribose] polymerase-1 ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase 1; DNA ADP-ribosyltransferase PARP1; ARTD1; ADPRT 1; ADPRT; ADP-ribosyltransferase diphtheria toxin-like 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [206] | |||
2 | Far Western | [207] | |||
3 | Reconstituted Complex | [206] | |||
Interacting Target Name | Nucleolin (NCL) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein C23; Nucleolin | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [208] | |||
2 | Far Western | [208] | |||
3 | Reconstituted Complex | [209] | |||
Interacting Target Name | Nucleophosmin (NPM1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Numatrin; Nucleolar protein NO38; Nucleolar phosphoprotein B23; NPM | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [210] | |||
3 | Reconstituted Complex | [211] | |||
Interacting Target Name | von Hippel-Lindau disease tumor suppressor (VHL) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | pVHL; Protein G7 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [212] | |||
2 | Affinity Capture-Western | [13] | |||
3 | Reconstituted Complex | [13] | |||
Interacting Protein Name | Apoptosis-stimulating of p53 protein 2 (TP53BP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 53BP2; ASPP2; BBP; P53BP2; PPP1R13A | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [213] | |||
2 | Reconstituted Complex | [196] | |||
3 | Yeast two hybrid | [196] | |||
Interacting Protein Name | BAG family molecular chaperone regulator 5 (BAG5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BAG.5 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [214] | |||
3 | Reconstituted Complex | [214] | |||
Interacting Protein Name | Coiled-coil domain-containing protein 8 (CCDC8) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 3M3; PPP1R20; p90 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [144] | |||
3 | Reconstituted Complex | [144] | |||
Interacting Protein Name | Promyelocytic leukemia protein (PML) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYL; PP8675; RNF71; TRIM19 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [215] | |||
2 | Co-localization | [23] | |||
3 | Reconstituted Complex | [215] | |||
Interacting Protein Name | General transcription factor IIH subunit 1 (GTF2H1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BTF2; P62; TFB1; TFIIH | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Co-crystal Structure | [41] | |||
2 | Far Western | [4] | |||
3 | Reconstituted Complex | [216] | |||
Interacting Target Name | Proliferating cell nuclear antigen (PCNA) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Cyclin | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [217] | |||
2 | Co-localization | [217] | |||
Interacting Target Name | Survival motor neuron protein (SMN1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Survival motor neuron protein; SMNT; SMNC; SMN2; SMN; Gemin-1; Component of gems 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Reconstituted Complex | [218] | |||
2 | Yeast two hybrid | [46] | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [98] | |||
2 | Co-localization | [219] | |||
Interacting Target Name | Suppressor of cytokine signaling 1 (SOCS1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TIP-3; TIP3; Tec-interacting protein 3; STAT-induced STAT inhibitor 1; STAT induced STAT inhibitor 1; SSI-1; SSI1; SOCS-1; JAK-binding protein; JAB | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [220] | |||
2 | Reconstituted Complex | [220] | |||
Interacting Protein Name | Axin-1 (AXIN1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AXIN; PPP1R49 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [221] | |||
2 | Reconstituted Complex | [222] | |||
Interacting Protein Name | BAG family molecular chaperone regulator 2 (BAG2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BAG.2; dJ417I1.2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [21] | |||
Interacting Protein Name | DnaJ homolog subfamily A member 1 (DNAJA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DJ.2; DjA1; HDJ2; HSDJ; HSJ2; HSPF4; NEDD7; hDJ.2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [223] | |||
Interacting Protein Name | Chimeric ERCC6-PGBD3 protein (CSB-PGBD3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ARMD5; CKN2; COFS; COFS1; CSB; RAD26; UVSS1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [224] | |||
2 | Reconstituted Complex | [5] | |||
Interacting Protein Name | Heterogeneous nuclear ribonucleoprotein K (HNRNPK) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CSBP; HNRPK; TUNP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [21] | |||
2 | Affinity Capture-Western | [225] | |||
Interacting Protein Name | RelA-associated inhibitor (PPP1R13L) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IASPP; NKIP1; RAI; RAI4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [226] | |||
Interacting Protein Name | Insulin-like growth factor 2-binding protein 1 (IGF2BP1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRD.BP; CRDBP; IMP.1; IMP1; VICKZ1; ZBP1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [38] | |||
Interacting Protein Name | Inhibitor of growth protein 4 (ING4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p29ING4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [227] | |||
2 | Reconstituted Complex | [228] | |||
Interacting Protein Name | Leucine-rich PPR motif-containing protein (LRPPRC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CLONE.23970; GP130; LRP130; LSFC | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [38] | |||
Interacting Protein Name | Metastasis-associated protein MTA2 (MTA2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MTA1L1; PID | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [52] | |||
2 | Reconstituted Complex | [52] | |||
Interacting Protein Name | Necdin (NDN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HsT16328; PWCR | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [229] | |||
2 | Reconstituted Complex | [230] | |||
Interacting Protein Name | Pituitary tumor-transforming gene 1 protein-interacting protein (PTTG1IP) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C21orf1; C21orf3; PBF | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [231] | |||
2 | Reconstituted Complex | [232] | |||
Interacting Protein Name | Retinoblastoma-binding protein 5 (RBBP5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RBQ3; SWD1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [233] | |||
2 | Reconstituted Complex | [127] | |||
Interacting Protein Name | Replication factor A protein 1 (RPA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HSSB; MST075; REPA1; RF.A; RP.A; RPA70 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [234] | |||
2 | Reconstituted Complex | [234] | |||
Interacting Protein Name | Transcription initiation factor TFIID subunit 9 (TAF9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MGC:5067; STAF31/32; TAF2G; TAFII.31; TAFII.32; TAFII31; TAFII32; TAFIID32 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Reconstituted Complex | [235] | |||
Interacting Protein Name | WW domain-containing oxidoreductase (WWOX) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | D16S432E; FOR; FRA16D; HHCMA56; PRO0128; SCAR12; SDR41C1; WOX1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [236] | |||
2 | Yeast two hybrid | [236] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem. 2002 Jun 21;277(25):22330-7. | ||||
REF 2 | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun. 2013;4:1531. | ||||
REF 3 | Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett. 2007 Jan 9;581(1):131-9. | ||||
REF 4 | Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 1996 Apr 1;15(7):1615-24. | ||||
REF 5 | p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet. 1995 Jun;10(2):188-95. | ||||
REF 6 | Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat Med. 2004 Dec;10(12):1321-8. | ||||
REF 7 | Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science. 2003 Apr 11;300(5617):342-4. | ||||
REF 8 | Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5762-7. | ||||
REF 9 | p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell. 1998 Oct;2(4):405-15. | ||||
REF 10 | Binding and modulation of p53 by p300/CBP coactivators. Nature. 1997 Jun 19;387(6635):823-7. | ||||
REF 11 | Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7009-14. | ||||
REF 12 | Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell. 2004 Jun 11;117(6):735-48. | ||||
REF 13 | p53 stabilization and transactivation by a von Hippel-Lindau protein. Mol Cell. 2006 May 5;22(3):395-405. | ||||
REF 14 | MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem. 2002 Aug 23;277(34):30838-43. | ||||
REF 15 | p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 1999 Feb;19(2):1202-9. | ||||
REF 16 | PCAF is a coactivator for p73-mediated transactivation. Oncogene. 2003 Nov 13;22(51):8316-29. | ||||
REF 17 | Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 2016 Jan 28;529(7587):541-5. | ||||
REF 18 | Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8797-801. | ||||
REF 19 | Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol. 1993 Feb;13(2):775-84. | ||||
REF 20 | The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004 May 6;429(6987):86-92. | ||||
REF 21 | Autophagic degradation of the inhibitory p53 isoform 133p53 as a regulatory mechanism for p53-mediated senescence. Nat Commun. 2014 Aug 21;5:4706. | ||||
REF 22 | CHIP chaperones wild type p53 tumor suppressor protein. J Biol Chem. 2007 Sep 28;282(39):28441-54. | ||||
REF 23 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 24 | Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell. 2001 Sep;8(3):713-8. | ||||
REF 25 | MBP1: a novel mutant p53-specific protein partner with oncogenic properties. Oncogene. 1999 Jun 17;18(24):3608-16. | ||||
REF 26 | Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7. | ||||
REF 27 | Protein interaction data set highlighted with human Ras-MAPK/PI3K signaling pathways. J Proteome Res. 2008 Sep;7(9):3879-89. | ||||
REF 28 | The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression. PLoS One. 2011;6(7):e22785. | ||||
REF 29 | Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3 ligase and regulates its stability. Biochem Biophys Res Commun. 2003 Feb 7;301(2):392-8. | ||||
REF 30 | EDD inhibits ATM-mediated phosphorylation of p53. J Biol Chem. 2011 Apr 29;286(17):14972-82. | ||||
REF 31 | BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression. J Biol Chem. 2009 Aug 21;284(34):22970-7. | ||||
REF 32 | TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro. Avicenna J Med Biotechnol. 2015 Apr-Jun;7(2):76-9. | ||||
REF 33 | Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition. J Biol Chem. 2003 Feb 14;278(7):4981-9. | ||||
REF 34 | p53 is involved in the p120E4F-mediated growth arrest. Oncogene. 2000 Jan 13;19(2):188-99. | ||||
REF 35 | ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell. 2005 Jul 1;121(7):1071-83. | ||||
REF 36 | Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage. Mol Cell Biol. 2008 Apr;28(8):2517-27. | ||||
REF 37 | OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017 Oct 19;36(42):5852-5860. | ||||
REF 38 | A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6322-7. | ||||
REF 39 | RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53. Biochem Biophys Res Commun. 2013 Nov 1;440(4):473-8. | ||||
REF 40 | Bladder polypoid cystitis-derived A20 associates with tumorigenesis. Cell Biochem Biophys. 2013 Nov;67(2):669-73. | ||||
REF 41 | Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell. 2006 Jun 23;22(6):731-40. | ||||
REF 42 | Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol. 2004 May;6(5):443-50. | ||||
REF 43 | Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. J Biol Chem. 2011 Aug 19;286(33):28749-60. | ||||
REF 44 | Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins. Oncotarget. 2014 Sep 30;5(18):8452-65. | ||||
REF 45 | Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Genes Dev. 2010 Oct 1;24(19):2194-204. | ||||
REF 46 | A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011 Sep 6;4(189):rs8. | ||||
REF 47 | Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Biochem Biophys Res Commun. 2014 Feb 28;445(1):120-5. | ||||
REF 48 | Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness. Biochem J. 2010 Feb 24;426(3):327-35. | ||||
REF 49 | Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun. 2001 Sep 7;286(5):1212-7. | ||||
REF 50 | Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene. 2001 Jan 11;20(2):240-51. | ||||
REF 51 | Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem. 2000 Jul 7;275(27):20436-43. | ||||
REF 52 | Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature. 2000 Nov 16;408(6810):377-81. | ||||
REF 53 | Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1. J Biol Chem. 2011 Feb 25;286(8):6311-20. | ||||
REF 54 | Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 2002 May 15;21(10):2383-96. | ||||
REF 55 | Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol. 2008 Aug;28(15):4745-58. | ||||
REF 56 | Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. EMBO J. 2004 Mar 10;23(5):1144-54. | ||||
REF 57 | Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene. 2010 May 27;29(21):3153-62. | ||||
REF 58 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 59 | Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding. Biochim Biophys Acta. 2007 Mar;1773(3):358-66. | ||||
REF 60 | CUL7 is a novel antiapoptotic oncogene. Cancer Res. 2007 Oct 15;67(20):9616-22. | ||||
REF 61 | Parc: a cytoplasmic anchor for p53. Cell. 2003 Jan 10;112(1):29-40. | ||||
REF 62 | PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell. 2003 Feb;3(2):117-30. | ||||
REF 63 | p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN. Cell Death Differ. 2014 Jan;21(1):146-60. | ||||
REF 64 | Identification of novel p53-binding proteins by biomolecular interaction analysis combined with tandem mass spectrometry. Mol Biotechnol. 2003 Mar;23(3):203-12. | ||||
REF 65 | ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53. Nat Commun. 2014 Oct 6;5:5059. | ||||
REF 66 | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012 Aug 31;150(5):987-1001. | ||||
REF 67 | Phosphorylation and hsp90 binding mediate heat shock stabilization of p53. J Biol Chem. 2003 Jan 17;278(3):2066-71. | ||||
REF 68 | Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein. J Mol Biol. 2004 Mar 12;337(1):129-45. | ||||
REF 69 | Hsp90 chaperones wild-type p53 tumor suppressor protein. J Biol Chem. 2004 Nov 19;279(47):48836-45. | ||||
REF 70 | HSP90 Shapes the Consequences of Human Genetic Variation. Cell. 2017 Feb 23;168(5):856-866.e12. | ||||
REF 71 | p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. Cancer Lett. 1994 Nov 25;87(1):39-46. | ||||
REF 72 | A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135). J Biol Chem. 2001 May 4;276(18):14649-57. | ||||
REF 73 | Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp Cell Res. 2002 Apr 1;274(2):246-53. | ||||
REF 74 | A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005 Sep 23;122(6):957-68. | ||||
REF 75 | The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature. 2002 Oct 24;419(6909):853-7. | ||||
REF 76 | Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J Biol Chem. 2002 Dec 13;277(50):47976-9. | ||||
REF 77 | The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10355-60. | ||||
REF 78 | Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status. Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1235-40. | ||||
REF 79 | Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function. EMBO J. 2002 Sep 2;21(17):4491-9. | ||||
REF 80 | A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2. Biochim Biophys Acta. 2013 Feb;1834(2):508-15. | ||||
REF 81 | COP9 subunits 4 and 5 target soluble guanylyl cyclase 1 and p53 in prostate cancer cells. Mol Endocrinol. 2014 Jun;28(6):834-45. | ||||
REF 82 | Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 2003 Mar 17;22(6):1302-12. | ||||
REF 83 | Tethering function of the caspase cleavage fragment of Golgi protein p115 promotes apoptosis via a p53-dependent pathway. J Biol Chem. 2011 Mar 11;286(10):8565-76. | ||||
REF 84 | Monitoring protein-protein interactions in mammalian cells by trans-SUMOylation. Biochem J. 2011 Sep 15;438(3):495-503. | ||||
REF 85 | JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases. Oncogene. 1997 Nov 6;15(19):2277-87. | ||||
REF 86 | Control of p53 multimerization by Ubc13 is JNK-regulated. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12676-81. | ||||
REF 87 | The effect of C-terminal fragment of JNK2 on the stability of p53 and cell proliferation. Cell Res. 2004 Oct;14(5):434-8. | ||||
REF 88 | JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis. J Biol Chem. 2003 Mar 14;278(11):9195-202. | ||||
REF 89 | ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet. 1998 Dec;20(4):398-400. | ||||
REF 90 | The DNA Damage Response Regulates RAG1/2 Expression in Pre-B Cells through ATM-FOXO1 Signaling. J Immunol. 2016 Oct 1;197(7):2918-29. | ||||
REF 91 | Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem. 1999 Dec 31;274(53):37538-43. | ||||
REF 92 | Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol Cell Biol. 2005 Jan;25(2):661-70. | ||||
REF 93 | Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J. 2005 Mar 23;24(6):1157-69. | ||||
REF 94 | Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 2001 Jul 15;15(14):1833-44. | ||||
REF 95 | BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage. J Biol Chem. 2004 Jul 23;279(30):31251-8. | ||||
REF 96 | Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol. 2002 Jan;4(1):1-10. | ||||
REF 97 | Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem. 2002 Aug 30;277(35):32020-8. | ||||
REF 98 | Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways. Neoplasia. 2002 Mar-Apr;4(2):171-80. | ||||
REF 99 | Regulatory interactions between the checkpoint kinase Chk1 and the proteins of the DNA-dependent protein kinase complex. J Biol Chem. 2003 Aug 8;278(32):29940-7. | ||||
REF 100 | Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J Cell Biol. 2004 Sep 13;166(6):801-13. | ||||
REF 101 | UV-induced interaction between p38 MAPK and p53 serves as a molecular switch in determining cell fate. FEBS Lett. 2010 Dec 1;584(23):4711-6. | ||||
REF 102 | Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med. 2005 Jan 17;201(2):279-89. | ||||
REF 103 | Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell. 2008 Jan 18;29(1):9-22. | ||||
REF 104 | Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells. Pharmacogenomics J. 2010 Apr;10(2):94-104. | ||||
REF 105 | The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene. 1999 Apr 29;18(17):2690-702. | ||||
REF 106 | PML enhances the regulation of p53 by CK1 in response to DNA damage. Oncogene. 2008 Jun 12;27(26):3653-61. | ||||
REF 107 | Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. FEBS Lett. 2006 Nov 27;580(27):6477-84. | ||||
REF 108 | Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7951-5. | ||||
REF 109 | Downregulation of the cdc2/cyclin B protein kinase activity by binding of p53 to p34(cdc2). Biochem Biophys Res Commun. 2001 May 4;283(2):507-12. | ||||
REF 110 | The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A. J Mol Biol. 2000 Jul 14;300(3):503-18. | ||||
REF 111 | Regulation of CAK kinase activity by p53. Oncogene. 1998 Nov 26;17(21):2733-41. | ||||
REF 112 | p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol. 1997 Dec;17(12):7220-9. | ||||
REF 113 | The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J Biol Chem. 2003 Aug 29;278(35):33134-41. | ||||
REF 114 | The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000 Feb 1;14(3):289-300. | ||||
REF 115 | MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein. J Biol Chem. 2010 Dec 10;285(50):38818-31. | ||||
REF 116 | Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1). J Cell Biochem. 2015 Dec;116(12):2903-14. | ||||
REF 117 | The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell. 2001 Jun;7(6):1307-19. | ||||
REF 118 | Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function. Int J Biochem Cell Biol. 2016 Jan;70:105-17. | ||||
REF 119 | Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res. 2000 Apr 1;60(7):1810-4. | ||||
REF 120 | Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. Mol Endocrinol. 2002 Feb;16(2):402-10. | ||||
REF 121 | An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stability. FEBS Lett. 2012 Apr 24;586(8):1135-40. | ||||
REF 122 | Cross-regulation of protein stability by p53 and nuclear receptor SHP. PLoS One. 2012;7(6):e39789. | ||||
REF 123 | Repression of p53 activity by Smyd2-mediated methylation. Nature. 2006 Nov 30;444(7119):629-32. | ||||
REF 124 | Regulation of p53 activity through lysine methylation. Nature. 2004 Nov 18;432(7015):353-60. | ||||
REF 125 | Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol. 2011 Oct 11;7:536. | ||||
REF 126 | The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics. 2008 Mar;7(3):560-72. | ||||
REF 127 | Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell. 2005 Jun 17;121(6):873-85. | ||||
REF 128 | Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen. Oncogene. 2001 Oct 18;20(47):6864-70. | ||||
REF 129 | Cyclooxygenase-2 functionally inactivates p53 through a physical interaction with p53. Biochim Biophys Acta. 2009 Aug;1793(8):1354-65. | ||||
REF 130 | COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis. Biochem Biophys Res Commun. 2005 Mar 25;328(4):1107-12. | ||||
REF 131 | p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol. 2008 Sep;28(17):5139-46. | ||||
REF 132 | p53 is regulated by the lysine demethylase LSD1. Nature. 2007 Sep 6;449(7158):105-8. | ||||
REF 133 | Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002 Apr 11;416(6881):648-53. | ||||
REF 134 | Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol. 2006 Mar;13(3):285-91. | ||||
REF 135 | Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7. J Mol Biol. 2010 Oct 8;402(5):825-37. | ||||
REF 136 | C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Arch Biochem Biophys. 2010 Nov 15;503(2):207-12. | ||||
REF 137 | Roles for CSN5 in control of p53/MDM2 activities. J Cell Biochem. 2008 Mar 1;103(4):1219-30. | ||||
REF 138 | COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 2001 Apr 2;20(7):1630-9. | ||||
REF 139 | OTUD5 regulates p53 stability by deubiquitinating p53. PLoS One. 2013 Oct 15;8(10):e77682. | ||||
REF 140 | USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010 Feb 5;140(3):384-96. | ||||
REF 141 | 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol. 2003 Oct;23(20):7096-107. | ||||
REF 142 | Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem. 2004 Oct 22;279(43):44475-82. | ||||
REF 143 | Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J Biol Chem. 2005 Jan 14;280(2):1543-51. | ||||
REF 144 | Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18937-42. | ||||
REF 145 | Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell. 2007 Apr 13;26(1):75-87. | ||||
REF 146 | Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011 Mar 10;471(7337):189-95. | ||||
REF 147 | Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein. Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1853-62. | ||||
REF 148 | Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation. Am J Physiol Renal Physiol. 2005 May;288(5):F899-909. | ||||
REF 149 | Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry. 2009 Feb 17;48(6):1244-55. | ||||
REF 150 | Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19290-5. | ||||
REF 151 | CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 1997 Sep 1;57(17):3693-6. | ||||
REF 152 | Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53. J Biol Chem. 2002 Nov 22;277(47):45028-33. | ||||
REF 153 | AP2alpha alters the transcriptional activity and stability of p53. Oncogene. 2006 Apr 6;25(15):2148-59. | ||||
REF 154 | Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J Biol Chem. 1993 Apr 15;268(11):7923-8. | ||||
REF 155 | DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Mol Cell. 2004 Dec 3;16(5):725-36. | ||||
REF 156 | The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol. 2003 Apr;23(8):2669-79. | ||||
REF 157 | CREB represses p53-dependent transactivation of MDM2 through the complex formation with p53 and contributes to p53-mediated apoptosis in response to glucose deprivation. Biochem Biophys Res Commun. 2011 Mar 4;406(1):79-84. | ||||
REF 158 | p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation. Mol Cell Biol. 2000 Jul;20(13):4849-58. | ||||
REF 159 | Metastasis-associated protein 1 inhibits p53-induced apoptosis. Oncol Rep. 2007 Nov;18(5):1311-4. | ||||
REF 160 | Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem. 2010 Mar 26;285(13):10044-52. | ||||
REF 161 | The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem. 2003 Oct 24;278(43):42560-8. | ||||
REF 162 | ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem. 2002 Mar 29;277(13):10804-12. | ||||
REF 163 | Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell. 2003 May 2;113(3):301-14. | ||||
REF 164 | Differential regulation of the REG-proteasome pathway by p53/TGF- signalling and mutant p53 in cancer cells. Nat Commun. 2013;4:2667. | ||||
REF 165 | Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 2003 Apr 18;278(16):13595-8. | ||||
REF 166 | Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10305-9. | ||||
REF 167 | Physical interaction between p53 and primary response gene Egr-1. Int J Oncol. 2001 Apr;18(4):863-70. | ||||
REF 168 | Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J Biol Chem. 2001 Mar 9;276(10):7534-40. | ||||
REF 169 | A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell. 2012 Sep 11;22(3):404-15. | ||||
REF 170 | Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene. 2008 Sep 18;27(42):5543-53. | ||||
REF 171 | Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function. Cancer Res. 2012 Apr 1;72(7):1740-50. | ||||
REF 172 | Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1. Cancer Invest. 2017 May 28;35(5):301-312. | ||||
REF 173 | Bach1 inhibits oxidative stress-induced cellular senescence by impeding p53 function on chromatin. Nat Struct Mol Biol. 2008 Dec;15(12):1246-54. | ||||
REF 174 | PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context. Cell Death Dis. 2013 Dec 12;4:e963. | ||||
REF 175 | The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells. Mol Biol Cell. 2014 Oct 1;25(19):3081-93. | ||||
REF 176 | Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2. Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13516-13521. | ||||
REF 177 | BAF60a interacts with p53 to recruit the SWI/SNF complex. J Biol Chem. 2008 May 2;283(18):11924-34. | ||||
REF 178 | Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol. 1994 Oct;68(10):6223-31. | ||||
REF 179 | YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12165-70. | ||||
REF 180 | Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. Am J Pathol. 2012 May;180(5):2120-33. | ||||
REF 181 | Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene. 2000 Dec 14;19(54):6194-202. | ||||
REF 182 | KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol. 2009 May;11(5):580-91. | ||||
REF 183 | NUMB controls p53 tumour suppressor activity. Nature. 2008 Jan 3;451(7174):76-80. | ||||
REF 184 | Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength. Nat Commun. 2014 Nov 11;5:5426. | ||||
REF 185 | Binding induced folding in p53-MDM2 complex. J Am Chem Soc. 2007 Mar 14;129(10):2930-7. | ||||
REF 186 | Reverse MAPPIT: screening for protein-protein interaction modifiers in mammalian cells. Nat Methods. 2005 Jun;2(6):427-33. | ||||
REF 187 | Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 1992 Jul 2;358(6381):80-3. | ||||
REF 188 | Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation. Biochem Pharmacol. 2011 Dec 1;82(11):1630-40. | ||||
REF 189 | Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 2007 Jan 10;26(1):113-22. | ||||
REF 190 | Regulation of p53 level by UBE4B in breast cancer. PLoS One. 2014 Feb 26;9(2):e90154. | ||||
REF 191 | UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat Med. 2011 Mar;17(3):347-55. | ||||
REF 192 | The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function. Cell Signal. 2015 Sep;27(9):1763-71. | ||||
REF 193 | Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 2002 Jul 15;21(14):3863-72. | ||||
REF 194 | An acetyl-methyl switch drives a conformational change in p53. Structure. 2015 Feb 3;23(2):322-31. | ||||
REF 195 | Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis. Protein Sci. 2004 Mar;13(3):617-25. | ||||
REF 196 | Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6098-102. | ||||
REF 197 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 198 | A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell. 2010 Nov 16;18(5):411-22. | ||||
REF 199 | A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time. Cell Rep. 2014 Dec 11;9(5):1946-1958. | ||||
REF 200 | Structural basis of how stress-induced MDMX phosphorylation activates p53. Oncogene. 2016 Apr 14;35(15):1919-25. | ||||
REF 201 | Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell. 2003 Nov;12(5):1087-99. | ||||
REF 202 | HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination. Oncogene. 2007 Jan 25;26(4):477-86. | ||||
REF 203 | p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 1996 Apr 15;15(8):1992-2002. | ||||
REF 204 | Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Nucleic Acids Res. 2003 Sep 15;31(18):5356-67. | ||||
REF 205 | Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53. Mol Cell Biol. 2003 Jan;23(1):322-34. | ||||
REF 206 | ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 1997 Oct 1;16(19):6018-33. | ||||
REF 207 | Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions. J Biol Chem. 1998 May 8;273(19):11839-43. | ||||
REF 208 | Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol Cell Biol. 2002 Aug;22(16):6014-22. | ||||
REF 209 | HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response. Sci Rep. 2015 Aug 4;5:12793. | ||||
REF 210 | Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol. 2002 Jul;4(7):529-33. | ||||
REF 211 | Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation. FEBS Lett. 2006 Jan 9;580(1):345-50. | ||||
REF 212 | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. J Proteome Res. 2011 Nov 4;10(11):5175-82. | ||||
REF 213 | Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). J Cell Sci. 2013 Jun 15;126(Pt 12):2629-40. | ||||
REF 214 | A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis. Cell Discov. 2016 Nov 1;2:16039. | ||||
REF 215 | The function of PML in p53-dependent apoptosis. Nat Cell Biol. 2000 Oct;2(10):730-6. | ||||
REF 216 | Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol. 1994 Oct;14(10):7013-24. | ||||
REF 217 | DNA damage tolerance pathway involving DNA polymerase and the tumor suppressor p53 regulates DNA replication fork progression. Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4311-9. | ||||
REF 218 | A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J Biol Chem. 2002 Jan 25;277(4):2852-9. | ||||
REF 219 | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature. 2016 Oct 6;538(7623):118-122. | ||||
REF 220 | SOCS1 links cytokine signaling to p53 and senescence. Mol Cell. 2009 Dec 11;36(5):754-67. | ||||
REF 221 | AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation. Oncogene. 2011 Mar 10;30(10):1194-204. | ||||
REF 222 | MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity. PLoS One. 2013 Jun 27;8(6):e67529. | ||||
REF 223 | DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway. Nat Cell Biol. 2016 Nov;18(11):1233-1243. | ||||
REF 224 | Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes. Mol Cell. 2000 May;5(5):801-10. | ||||
REF 225 | SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage. EMBO J. 2012 Nov 28;31(23):4441-52. | ||||
REF 226 | iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet. 2003 Feb;33(2):162-7. | ||||
REF 227 | p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 2003 May 15;63(10):2373-8. | ||||
REF 228 | Nuclear localization signal of ING4 plays a key role in its binding to p53. Biochem Biophys Res Commun. 2005 Jun 17;331(4):1032-8. | ||||
REF 229 | Necdin controls proliferation and apoptosis of embryonic neural stem cells in an oxygen tension-dependent manner. J Neurosci. 2013 Jun 19;33(25):10362-73. | ||||
REF 230 | Physical and functional interactions of neuronal growth suppressor necdin with p53. J Biol Chem. 1999 Jun 4;274(23):16242-8. | ||||
REF 231 | The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer. Mol Carcinog. 2016 Jan;55(1):15-26. | ||||
REF 232 | The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells. Endocrinology. 2014 Apr;155(4):1222-34. | ||||
REF 233 | SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell. 2013 Jul 18;154(2):297-310. | ||||
REF 234 | The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene. 2004 Dec 2;23(56):9025-33. | ||||
REF 235 | Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc Natl Acad Sci U S A. 1995 May 23;92(11):5154-8. | ||||
REF 236 | Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem. 2001 Feb 2;276(5):3361-70. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.